In our “Up Front” column in the April issue, we discussed the new device tax included in the new health care reform bill and what it might mean to the industry. “Section 9009; Imposition of Annual Fee on Medical Device Manufacturers and Importers,” provides for a 2.3% excise tax to begin in 2013.
G. Wayne Moore, BSc, MBA, FASE, president, advanced development group and chief strategy officer of Unisyn Medical Technologies, said: “The new 2.3% tax will put additional pressure on innovation, as the base cost to bring new novel medical products to market will increase,” Moore said. “Some companies, such as Medtronic, have already indicated that the new tax will cause them to lay off some employees as well as throttle back on advanced research and development initiatives.”
What do you think about this? If you work for a device company, have any changes been discussed in light of the new bill? Click on the comment tab and let us know your thoughts.